Cleared Traditional

K190893 - Non-invasive Hemodynamic Blood Pressure...

K190893 is the FDA 510(k) clearance for Non-invasive Hemodynamic Blood Pressure... by Vita-Course Technologies Co., Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 124-day FDA review.

K190893 · Vita-Course Technologies Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2019
Decision
124d
Days
Class 2
Risk

K190893 is an FDA 510(k) clearance for the Non-invasive Hemodynamic Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Vita-Course Technologies Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on August 7, 2019 after a review of 124 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vita-Course Technologies Co., Ltd. devices

Submission Details

510(k) Number K190893 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 05, 2019
Decision Date August 07, 2019
Days to Decision 124 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 125d · This submission: 124d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Chonconn Medical Device Consulting Co., Ltd.
Kevin Wang

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K190893.
EV1000 Clinical Platform NI, EV1000 Clinical Platform
K192058 · Edwards Lifesciences, LLC · Aug 2019
Electronic Blood Pressure Monitor
K191180 · Shenzhen AOJ Medical Technology Co., Ltd. · Aug 2019
Blood Pressure Monitor
K190207 · Shenzhen Viatom Technology Co., Ltd. · Aug 2019
Med-link Wrist Digital Blood Pressure Monitor, Med-link Upper Arm Digital Blood Pressure Monitor
K181154 · Shenzhen Med-Link Electronics Tech Co., Ltd. · Aug 2019
Non-invasive blood pressure measurement systems
K190886 · Joytech Healthcare Co. , Ltd. · Jul 2019
Digital Automatic Blood Pressure Monitor MD36 Series
K191593 · Grandway Technology (Shenzhen) Limited · Jul 2019